Cover Image
市場調查報告書

D-Pharm Ltd.:產品平台分析

D-Pharm Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256079
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
D-Pharm Ltd.:產品平台分析 D-Pharm Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 33 Pages
簡介

D-Pharm Ltd.是總公司設立於以色列的技術導向生物製藥企業,從事中樞神經系統疾病治療藥的藥物研發,開發,商品化。特別致力於退化性疾病及老齡化性疾病的藥物開發。產品系列有血栓溶解劑的THR-18,癲癇,偏頭痛及躁鬱症治療藥的DP-VPA,減輕急性胰炎造成的細胞緊張狀態之DP-b99等。

本報告提供D-Pharm Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

D-Pharm Ltd. 的基本資料

  • D-Pharm Ltd. 概要
  • 主要資訊
  • 企業資料

D-Pharm Ltd. :R&D概要

  • 主要的治療範圍

D-Pharm Ltd. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

D-Pharm Ltd. :開發中產品概況

  • 臨床階段的開發中產品
    • 第Ⅱ相的產品/聯合治療模式
    • 第Ⅰ相的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA登記前的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式

D-Pharm Ltd. :藥物簡介

  • DP-VPA
  • DPB-99
  • THR-18
  • DP-NDD

D-Pharm Ltd. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

D-Pharm Ltd.:最近的開發平台形勢

D-Pharm Ltd.:開發暫停中的計劃

D-Pharm Ltd.:開發中止的開發中產品

D-Pharm Ltd.:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07452CDB

Summary

Global Markets Direct's, 'D-Pharm Ltd. - Product Pipeline Review - 2015', provides an overview of the D-Pharm Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of D-Pharm Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of D-Pharm Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of D-Pharm Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the D-Pharm Ltd.'s pipeline products

Reasons to buy

  • Evaluate D-Pharm Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of D-Pharm Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the D-Pharm Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of D-Pharm Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of D-Pharm Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of D-Pharm Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • D-Pharm Ltd. Snapshot
    • D-Pharm Ltd. Overview
    • Key Information
    • Key Facts
  • D-Pharm Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • D-Pharm Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • D-Pharm Ltd. - Pipeline Products Glance
    • D-Pharm Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • D-Pharm Ltd. - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • D-Pharm Ltd. - Drug Profiles
    • DP-VPA
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DPB-99
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • THR-18
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DP-NDD
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • D-Pharm Ltd. - Pipeline Analysis
    • D-Pharm Ltd. - Pipeline Products by Target
    • D-Pharm Ltd. - Pipeline Products by Route of Administration
    • D-Pharm Ltd. - Pipeline Products by Molecule Type
    • D-Pharm Ltd. - Pipeline Products by Mechanism of Action
  • D-Pharm Ltd. - Recent Pipeline Updates
  • D-Pharm Ltd. - Dormant Projects
  • D-Pharm Ltd. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • DPB-99
  • D-Pharm Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • D-Pharm Ltd., Key Information
  • D-Pharm Ltd., Key Facts
  • D-Pharm Ltd. - Pipeline by Indication, 2015
  • D-Pharm Ltd. - Pipeline by Stage of Development, 2015
  • D-Pharm Ltd. - Monotherapy Products in Pipeline, 2015
  • D-Pharm Ltd. - Phase II, 2015
  • D-Pharm Ltd. - Phase I, 2015
  • D-Pharm Ltd. - IND/CTA Filed, 2015
  • D-Pharm Ltd. - Preclinical, 2015
  • D-Pharm Ltd. - Pipeline by Target, 2015
  • D-Pharm Ltd. - Pipeline by Route of Administration, 2015
  • D-Pharm Ltd. - Pipeline by Molecule Type, 2015
  • D-Pharm Ltd. - Pipeline Products by Mechanism of Action, 2015
  • D-Pharm Ltd. - Recent Pipeline Updates, 2015
  • D-Pharm Ltd. - Dormant Developmental Projects,2015
  • D-Pharm Ltd. - Discontinued Pipeline Products, 2015
  • D-Pharm Ltd., Other Locations
  • D-Pharm Ltd., Subsidiaries

List of Figures

  • D-Pharm Ltd. - Pipeline by Top 10 Indication, 2015
  • D-Pharm Ltd. - Pipeline by Stage of Development, 2015
  • D-Pharm Ltd. - Monotherapy Products in Pipeline, 2015
  • D-Pharm Ltd. - Pipeline by Top 10 Target, 2015
  • D-Pharm Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • D-Pharm Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • D-Pharm Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top